Korean J Dermatol.
2002 May;40(5):536-539.
A Case of Vitiligo Induced by Diphenylcyclopropenone in a Patient with Malignant Melanoma
- Affiliations
-
- 1Department of Dermatology, College of Medicine, Hallym University Seoul, Korea. kim937121@hanmail.net
Abstract
- DPCP(diphencyclopropenone) has been used for the treatment of alopecia areata or verruca. Common side effects due to topical treatment with DPCP are pruritus, blistering, cervical lymphadenopathy and urticaria. Rarely, vitiligo can be induced by topical treatment with DPCP as a complication on the pigmentary system. Herein we report a case of vitiligo induced by DPCP in a patient with malignant melanoma. She was diagnosed with malignant melanoma in her 4th toe, Rt., a year ago. As part of adjuvant therapy, DPCP was topically applied to the inguinal area every week. After 4 months, vitiligo appeared on the area of DPCP application.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A case of vitiligo associated with malignant melanoma
- Halo Seborrheic Keratosis in a Patient with Vitiligo
- Disappearing Atypical Lentiginous Pigmentation of the Desmoplastic Malignant Melanoma
- Vitiligo-like Depigmentation Associated with Metastatic Melanoma of an Unknown Origin
- A Case of Malignant Melanoma of the Conjunctiva
